Brain and Behavior · 2017 · 42 citations · 34 references
Life SciencesMolecular BiologyPsychiatryGene ExpressionGene Expression AnalysisTranscriptomicsGene Expression ProfilingNoncoding Rna BiologyNoncoding Rna TranscriptomicsSuicide Risk AssessmentTranscriptomic AnalysisTranscriptomic ProfilingLong Non-coding Ribonucleic AcidsLong Non-coding Rna BiomarkersLong Noncoding Rna Expression AnalysisLong Noncoding Rna ProfilingNon-coding Rna ProfilingNoncoding Rna Differential Expression AnalysisNoncoding Rna Expression ProfilingSuicide Attempt Risk
BACKGROUND: WHO stated that nearly one million people commit suicide every year worldly, and 40% of the suicide completer suffered from depression. The primary aim of this study was to explore the association between long noncoding RNAs (lncRNAs) expression in peripheral blood mononuclear cells (PBMCs) and suicide risk of patients with major depressive disorder (MDD). METHODS: Using Human LncRNA 3.0 microarray profiling which includes 30,586 human lncRNAs and RT-PCR, six down-regulated lncRNAs were identified differentially expressed in MDD patients. According to suicidal ideation and suicidal attempt, the suicide risk of MDD patients was classified into suicidal ideation versus no suicidal ideation groups, and past attempt versus no past attempt groups, respectively. The expression of six lncRNAs in MDD patients and controls were examined by RT-PCR. RESULTS: The expression of six lncRNAs had significant differences between no suicidal ideation, suicidal ideation, and controls; corresponding lncRNAs associated with suicidal attempt had remarkable differences between no past attempt, past attempt, and controls. Additionally, only the expression of lncRNAs in suicidal ideation group and past attempt group markedly declined compared with controls. CONCLUSIONS: This study indicated that the expression of six down-regulated lncRNAs had a negative association with suicide risk in MDD patients, and the expression of lncRNAs in PBMCs could have the potential to help clinician judge the suicide risk of MDD patients to provide timely treatment and prevent suicide.
34
Suicide Risk in Bipolar Disorder During Treatment With Lithium and Divalproex
Frederick K. Goodwin · JAMA · 2003 · 530 citations
Marsha M. Linehan, Katherine Anne Comtois, Milton Z. Brown et al. · Psychological Assessment · 2006 · 484 citations